drugset / Trial / NCT00245258

Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction

NCT00245258

Phase 4 Completed 312 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The study objective is to: 1. To evaluate the effect of sildenafil citrate versus placebo on the IIEF\_EF Domain at the end of the double-blind phase 2. To assess the relationship between treatment with sildenafil citrate or placebo and responses to the Quality of Erection Questionnaire (QEQ) and Sexual Experience Questionnaire (SEX\_Q).

Timeline

Start
2005-11
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg
Subject Sildenafil Unknown 100 mg

Indications